论文部分内容阅读
交感神经、肾素-血管紧张素-醛固酮系统激活的干预措施在心力衰竭的治疗中发挥了积极作用,并在一定程度上改善了心力衰竭的预后,但心力衰竭的病死率及病残率仍很高。近年来在治疗心力衰竭的新药及新技术研究方面取得不少进展。有些新药尚缺少儿科病例应用的经验。因此,采用成人病例治疗经验时必须结合儿科病例的特点。
Sympathetic, renin-angiotensin-aldosterone system-activated interventions have played a positive role in the treatment of heart failure and to a certain extent improved the prognosis of heart failure, but the mortality and morbidity of heart failure still High. In recent years, a lot of progress has been made in the research of new drugs and new technologies for treating heart failure. Some new drugs are lacking in pediatric case application experience. Therefore, the experience of using adult cases must be combined with the characteristics of pediatric cases.